Simon Garinet

ORCID

Publication Activity (10 Years)

Years Active: 2021-2023
Publications (10 Years): 9

Top Venues

Journal of translational medicine

Cancers

British journal of cancer

This page only lists publications with an associated author ORCID identifier.

Publications

Simon Garinet, Audrey Didelot, Laetitia Marisa, Guillaume Beinse, Marine Sroussi, Françoise Le Pimpec-Barthes, Elizabeth Fabre, Laure Gibault, Pierre Laurent-Puig, Sophie Mouillet-Richard, Antoine Legras, Hélène Blons
A novel Chr1-miR-200 driven whole transcriptome signature shapes tumor immune microenvironment and predicts relapse in early-stage lung adenocarcinoma. Journal of translational medicine 21 (1) (2023)
Simon Garinet, Audrey Didelot, Laetitia Marisa, Guillaume Beinse, Marine Sroussi, Françoise Le Pimpec-Barthes, Elizabeth Fabre, Laure Gibault, Pierre Laurent-Puig, Sophie Mouillet-Richard, Antoine Legras, Hélène Blons
A novel Chr1-miR-200 driven whole transcriptome signature shapes tumor immune microenvironment and predicts relapse in early-stage lung adenocarcinoma. Journal of translational medicine 21 (1) (2023)
Simon Garinet, Audrey Didelot, Laetitia Marisa, Guillaume Beinse, Marine Sroussi, Françoise Le Pimpec-Barthes, Elizabeth Fabre, Laure Gibault, Pierre Laurent-Puig, Sophie Mouillet-Richard, Antoine Legras, Hélène Blons
A novel Chr1-miR-200 driven whole transcriptome signature shapes tumor immune microenvironment and predicts relapse in early-stage lung adenocarcinoma. Journal of translational medicine 21 (1) (2023)
Simon Garinet, Audrey Didelot, Laetitia Marisa, Guillaume Beinse, Marine Sroussi, Françoise Le Pimpec-Barthes, Elizabeth Fabre, Laure Gibault, Pierre Laurent-Puig, Sophie Mouillet-Richard, Antoine Legras, Hélène Blons
A novel Chr1-miR-200 driven whole transcriptome signature shapes tumor immune microenvironment and predicts relapse in early-stage lung adenocarcinoma. Journal of translational medicine 21 (1) (2023)
Guillaume Beinse, Pierre-Alexandre Just, Marie-Aude Le Frere Belda, Pierre Laurent-Puig, Sebastien Jacques, Meriem Koual, Simon Garinet, Karen Leroy, Nicolas Delanoy, Helene Blons, Claire Gervais, Catherine Durdux, Charles Chapron, François Goldwasser, Benoit Terris, Cecile Badoual, Valérie Taly, Anne-Sophie Bats, Bruno Borghese, Jérôme Alexandre
Discovery and validation of a transcriptional signature identifying homologous recombination-deficient breast, endometrial and ovarian cancers. British journal of cancer 127 (6) (2022)
Simon Garinet, Pascal Wang, Audrey Mansuet-Lupo, Ludovic Fournel, Marie Wislez, Hélène Blons
Updated Prognostic Factors in Localized NSCLC. Cancers 14 (6) (2022)
Emilie Moati, Valerie Taly, Simon Garinet, Audrey Didelot, Gilles Manceau, Pierre Laurent-Puig, Aziz Zaanan
Role of Circulating Tumor DNA in Gastrointestinal Cancers: Current Knowledge and Perspectives. Cancers 13 (19) (2021)
Arnaud Bayle, Debora Basile, Simon Garinet, Bastien Rance, Pierre Laurent-Puig, Hélène Blons, Gilles Manceau, Geraldine Perkins
Next-Generation Sequencing Targeted Panel in Routine Care for Metastatic Colon Cancers. Cancers 13 (22) (2021)
Simon Garinet, Audrey Didelot, Thomas Denize, Alexandre Perrier, Guillaume Beinse, Jean-Baptiste Leclere, Jean-Baptiste Oudart, Laure Gibault, Cecile Badoual, Françoise Le Pimpec-Barthes, Pierre Laurent-Puig, Antoine Legras, Helene Blons
Clinical assessment of the miR-34, miR-200, ZEB1 and SNAIL EMT regulation hub underlines the differential prognostic value of EMT miRs to drive mesenchymal transition and prognosis in resected NSCLC. British journal of cancer 125 (11) (2021)

Simon Garinet.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Simon Garinet